In Brief: SmithKline Beecham/TCPI
This article was originally published in The Gray Sheet
Executive Summary
SmithKline Beecham/TCPI: Enter agreement whereby SKB will evaluate for a six-month period Technical Chemicals & Products' TD Glucose Monitoring System, a point-of-care, non-invasive blood glucose monitoring technology. In return, SKB provides TCPI with up-front payments, and agrees to a mutual exchange of technical and marketing information related to the product. SKB has until the end of the six-month period to conduct due diligence, perform market studies and negotiate a definitive worldwide marketing agreement related to the test...